Pediatric Cancer Predisposition Imaging: Focus on Whole-Body MRI

Clin Cancer Res. 2017 Jun 1;23(11):e6-e13. doi: 10.1158/1078-0432.CCR-17-0515.

Abstract

The American Association for Cancer Research convened a meeting of international pediatric oncologists, geneticists, genetic counselors, and radiologists expert in childhood cancer predisposition syndromes (CPS) in October 2016 to propose consensus surveillance guidelines. Imaging plays a central role in surveillance for most, though not all, syndromes discussed. While encompassing the full gamut of modalities, there is increasing emphasis on use of nonionizing radiation imaging options such as magnetic resonance imaging (MRI) in children and adolescents, especially in the pediatric CPS population. In view of rapid evolution and widespread adoption of whole-body MRI (WBMRI), the purpose of our review is to address WBMRI in detail. We discuss its place in the surveillance of a range of pediatric CPS, the technical and logistical aspects of acquiring and interpreting these studies, and the inherent limitations of WBMRI. We also address issues associated with sedation and use of gadolinium-based contrast agents in MRI in children. Clin Cancer Res; 23(11); e6-e13. ©2017 AACRSee all articles in the online-only CCR Pediatric Oncology Series.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Early Detection of Cancer / methods*
  • Gadolinium / therapeutic use
  • Genetic Predisposition to Disease
  • Humans
  • Magnetic Resonance Imaging / methods*
  • Neoplasms / diagnosis
  • Neoplasms / diagnostic imaging*
  • Neoplasms / pathology
  • Whole Body Imaging / methods*

Substances

  • Gadolinium